SCHEMBL29879743

SCHEMBL29879743

CONc1cc(NCc2cn3cc(C4CC4)cc(N4CCN(C)CC4)c3n2)cnn1

nearest known ligand 0.34

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ HRH4 Q9H3N8 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24737990 1.00 HRH4 (0.34) HRH4
SCHEMBL29879251 0.88 HRH4 (0.32) HRH4
SCHEMBL24737991 0.88 HRH4 (0.32) HRH4
SCHEMBL24737988 0.86 HDAC3 (0.33) HRH4
SCHEMBL24737671 0.84 — —
SCHEMBL29136929 0.78 METTL3 (0.41) —
SCHEMBL30997769 0.78 HRH1 (0.38) HRH4
SCHEMBL24738259 0.78 HRH1 (0.38) HRH4
SCHEMBL29879323 0.78 MAP4K1 (0.33) —
SCHEMBL24737878 0.76 DRD2 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4308230-A1 HETEROARYL INHIBITORS OF PLASMA KALLIKREIN Takeda Pharmaceutical Company Limited (JP) 2024-01-24 — — EP disclosed
WO-2022197758-A1 HETEROARYL INHIBITORS OF PLASMA KALLIKREIN SHIRE HUMAN GENETIC THERAPIES, INC. (US) 2022-09-22 — — WO disclosed
Send feedback